Skip to main content

AlphaCentric Advisors LLC

SEC CIK
0001913464
Latest filing
Jul 24, 2026

RAPP holding history

Rapport Therapeutics, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPP overviewAll 13F holders of RAPPFull Q2 2026 holdings

Shares (Q2 2026)
6,531
Value
$272.1K
% of portfolio
0.2%
Quarters held
3
Since Q4 2025
Holdings of RAPP by AlphaCentric Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,531$272.1K0.2%+93+1.4%AddedHolders
Q1 20266,438$201.4K0.2%+408+6.8%AddedHolders
Q4 20256,030$182.9K0.2%–No prior filingHolders